Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. STRA
STRA logo

STRA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Strategic Education Inc (STRA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
83.210
1 Day change
1.60%
52 Week Range
93.450
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Strategic Education Inc (STRA) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown positive financial growth in the latest quarter, the lack of strong trading signals, neutral sentiment from hedge funds and insiders, and a downgrade in analyst ratings suggest that the stock does not present an immediate compelling opportunity. The investor should consider waiting for stronger positive catalysts or improved trading signals before committing funds.

Technical Analysis

The technical indicators show a neutral trend. The MACD is below zero and negatively contracting, indicating weak momentum. RSI is neutral at 54.266, and moving averages are converging, suggesting no clear directional trend. The stock is trading near its pivot level of 82.017, with resistance at 84.594 and support at 79.441.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market. However, the low volume suggests limited activity, reducing the reliability of this signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
8

Positive Catalysts

  • Financial performance in Q4 2025 was strong, with revenue up 3.77% YoY, net income up 49.63% YoY, and EPS up 58.10% YoY.

  • Gross margin increased to 50.51%, reflecting improved operational efficiency.

  • Partnership with NurseDash to offer discounted courses could drive incremental revenue and brand recognition.

Neutral/Negative Catalysts

  • Truist downgraded the stock to Hold from Buy, citing subdued demand and challenges in meeting revenue estimates.

  • U.S. enrollment trends remain weak, posing a structural challenge for the company.

  • No significant hedge fund or insider activity to indicate confidence in the stock.

Financial Performance

The company's Q4 2025 financials showed strong growth: Revenue increased to $323.21M (up 3.77% YoY), Net Income rose to $37.91M (up 49.63% YoY), EPS increased to 1.66 (up 58.10% YoY), and Gross Margin improved to 50.51% (up 8.81% YoY). This indicates operational efficiency and profitability improvements.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Truist recently downgraded the stock to Hold from Buy, with a reduced price target of $85 (down from $95). Analysts cite subdued demand and challenges in meeting revenue estimates. Previous ratings also showed a downward revision in price targets, reflecting cautious sentiment.

Wall Street analysts forecast STRA stock price to rise
3 Analyst Rating
Wall Street analysts forecast STRA stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 83.210
sliders
Low
85
Averages
95
High
105
Current: 83.210
sliders
Low
85
Averages
95
High
105
Truist
Jasper Bibb
Buy -> Hold
downgrade
$95 -> $85
AI Analysis
2026-03-24
Reason
Truist
Jasper Bibb
Price Target
$95 -> $85
AI Analysis
2026-03-24
downgrade
Buy -> Hold
Reason
Truist analyst Jasper Bibb downgraded Strategic Education to Hold from Buy with a price target of $85, down from $95. The firm sees a "more difficult path" for Strategic Education to meet consensus revenue estimates in 2026. Demand remains "subdued" at Strayer and Education Technology Services faces tougher comps against year one of its large retail relationship, the analyst tells investors in a research note. Truist thinks U.S. higher education needs to return to enrollment growth to "get the stock working again."
Truist
Jasper Bibb
Buy
downgrade
$105 -> $95
2026-03-02
Reason
Truist
Jasper Bibb
Price Target
$105 -> $95
2026-03-02
downgrade
Buy
Reason
Truist analyst Jasper Bibb lowered the firm's price target on Strategic Education to $95 from $105 and keeps a Buy rating on the shares. The company reported a mixed Q4 where US enrollment declined more steeply than forecast, but EBITDA beat on a combination of cost cutting and AI-driven efficiencies, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for STRA
Unlock Now

People Also Watch